CompletedPhase 2NCT03033108
Pharmacodynamic Study of Emixustat Hydrochloride in Subjects With Macular Atrophy Secondary to Stargardt Disease
Studying Familial anetoderma
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Kubota Vision Inc.
- Principal Investigator
- Acucela Medical Director, MDKubota Vision Inc.
- Intervention
- Emixustat(drug)
- Enrollment
- 23 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2017 – 2017
Study locations (1)
- Dallas, Texas, United States
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT03033108 on ClinicalTrials.govOther trials for Familial anetoderma
Additional recruiting or active studies for the same condition.